TECH vs VRTS
Bio-Techne Corp (TECH) versus Virtus Investment Partners, Inc. (VRTS) — a side-by-side from cached financials, not a winner call.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Virtus Investment Partners, Inc. (VRTS) is a asset management company listed on NYSE.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Latest reported VRTS revenue for 2024-12-31 was $906.9M. Net income was $152.5M. Revenue was up 7.3% from 2023-12-31 to 2024-12-31. VRTS currently screens at market cap $957.7M and trailing P/E 8.5.
TECH currently screens at market cap $8.49B and trailing P/E 65.2. VRTS currently screens at market cap $957.7M and trailing P/E 8.5.
Not investment advice. Open the TECH and VRTS stock pages for the full models.
Not investment advice.